European industry bodies voice concern over CoE's anti-counterfeiting system
This article was originally published in SRA
Moves towards implementing a Europe-wide system for verifying the authenticity of medicines are gathering pace as representatives of the pharmaceutical industry and distributors prepare to sign an agreement on what they say will be a "practical and cost-effective solution" to implementing the requirements of the new EU legislation on falsified medicines.
You may also be interested in...
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
EU trade expert Hervé Jouanjean considers the reasoning behind the EU’s vaccine procurement approach and Italy's decision to block exports of AstraZeneca's COVID-19 vaccine.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.